‘Actin-reactive’ discriminated from ‘non-actin-reactive’ smooth muscle autoantibody by immunofluorescence reactivity with rat epithelial cell line

References

• Vergani D, Alvarez F, Bianchi FB, et al Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 2004; 41: 677–683.
   PubMed Web of Science ®Google Scholar
• Mackay IR, Toh BH. Autoimmune hepatitis: the way we were, the way we are today and the way we hope to be. (Review.) Autoimmunity 2002; 35: 293–305.
   PubMed Web of Science ®Google Scholar
• Whittingham S, Mackay IR, Irwin J. Autoimmune hepatitis. Immunofluorescence reactions with cytoplasm of smooth muscle and renal glomerular cells. Lancet 1966; 1: 1333–1335.
   PubMed Web of Science ®Google Scholar
• Gabbiani G, Ryan GB, Lamelin JP, et al Human smooth muscle autoantibody. Its identification as antiactin antibody and a study of its binding to ‘nonmuscular’ cells. Am J Pathol 1973; 72: 473–488.
   PubMed Web of Science ®Google Scholar
• Toh BH, Clarke FM, Ceredig R. Reaction of human smooth muscle autoantibody with skeletal muscle, cardiac muscle, and thymic myoid cells. Clin Immunol Immunopathol 1978; 9: 28–36.
   PubMedGoogle Scholar
• Ceredig R, Toh BH. Reaction of human smooth muscle autoantibody with gastric parietal cells: a pitfall in the diagnosis of parietal cell autoantibody. J Clin Pathol 1977; 30: 666–670.
   PubMed Web of Science ®Google Scholar
• Toh BH, Gallichio HA, Jeffrey PL, et al Anti-actin stains synapses. Nature 1976; 264: 648–650.
   PubMed Web of Science ®Google Scholar
• Toh BH, Hard CC. Actin co-caps with concanavalin A receptors. Nature 1977; 269: 695–697.
   PubMedGoogle Scholar
• Toh BH, Muller HK. Smooth muscle-associated antigen in experimental cutaneous squamous cell carcinoma, keratoacanthoma, and papilloma. Cancer Res 1975; 35: 3741–3745.
   PubMedGoogle Scholar
• Harmer JH, Lolait SJ, Toh BH, Pedersen JS, Chaponnier C, Gabbiani G. Actin depolymerizing factor and the organization and distribution of actin in astrocytomas and meningiomas. Br J Cancer 1983; 48: 89–93.
   PubMedGoogle Scholar
• Bottazzo GF, Florin-Christensen A, Fairfax A, Swana G, Doniach D, Groeschel-Stewart U. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 1976; 29: 403–410.
   PubMed Web of Science ®Google Scholar
• Kurki P, Linder E, Miettinen A, Alfthan O. Smooth muscle antibodies of actin and ‘non-actin’ specificity. Clin Immunol Immunopathol 1978; 9: 443–453.
   PubMedGoogle Scholar
• Lidman K, Biberfeld G, Fagraeus A, et al Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis. Clin Exp Immunol 1976; 24: 266–272.
   PubMed Web of Science ®Google Scholar
• Andersen P, Small JV, Sobieszek A. Studies on the specificity of smooth-muscle antibodies. Clin Exp Immunol 1976; 26: 57–66.
   PubMedGoogle Scholar
• Kurki P, Linder E, Virtanen I, Stenman S. Human smooth muscle autoantibodies reacting with intermediate (100 A) filaments. Nature 1977; 268: 240–241.
   PubMed Web of Science ®Google Scholar
• Kurki P, Virtanen I. The detection of smooth muscle antibodies reacting with intermediate filaments of desmin type. J Immunol Methods 1985; 76: 329–335.
   PubMedGoogle Scholar
• Toh BH. Smooth muscle autoantibodies and autoantigens. Clin Exp Immunol 1979; 38: 621–628.
   PubMed Web of Science ®Google Scholar
• Kurki P, Virtanen I. The detection of human antibodies against cytoskeletal components. (Review.) J Immunol Methods 1984; 67: 209–223.
   PubMed Web of Science ®Google Scholar
• Toh BH. Anti-cytoskeletal autoantibodies: diagnostic significance for liver diseases, infections and systemic autoimmune diseases. (Review.) Autoimmunity 1991; 11: 119–125.
   PubMed Web of Science ®Google Scholar
• Bretherton L, Toh BH. IgM autoantibody to intermediate filaments in infectious mononucleosis. J Clin Lab Immunol 1981; 5: 7–10.
   PubMedGoogle Scholar
• Linder E, Kurki P, Andersson LC. Autoantibody to ‘intermediate filament’ in infectious mononucleosis. Clin Immunol Immunopathol 1979; 14: 411–417.
   PubMedGoogle Scholar
• Toh BH, Yildiz A, Sotelo J, et al Viral infections and IgM autoantibodies to cytoplasmic intermediate filaments. Clin Exp Immunol 1979; 37: 76–82.
   PubMedGoogle Scholar
• Pedersen JS, Toh BH, Mackay IR, et al Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis. Clin Exp Immunol 1982; 48: 527–532.
   PubMed Web of Science ®Google Scholar
• Brown C, Pedersen J, Underwood JR, Gust I, Toh BH. Autoantibodies to intermediate filaments in acute viral hepatitis A, B and non-A, non-B are directed against vimentin. J Clin Lab Immunol 1986; 19: 1–4.
   PubMedGoogle Scholar
• Bretherton L, Toh BH, Jack I. IgM autoantibody to intermediate filaments in Mycoplasma pneumoniae infections. Clin Immunol Immunopathol 1981; 18: 425–430.
   PubMedGoogle Scholar
• Alcover A, Molano J, Renart J, Gil-Aguado A, Nieto A, Avila J. Antibodies to vimentin intermediate filaments in sera from patients with systemic lupus erythematosus. Arthritis Rheum 1984; 27: 922–928.
   PubMedGoogle Scholar
• Granito A, Muratori L, Muratori P, et al Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis. J Clin Pathol 2006; 59: 280–284.
   PubMed Web of Science ®Google Scholar
• Frenzel C, Herkel J, Luth S, Galle PR, Schramm C, Lohse AW. Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis. Am J Gastroenterol 2006; 101: 2731–2736.
   PubMed Web of Science ®Google Scholar
• Liaskos C, Bogdanos DP, Davies ET, Dalekos GN. Diagnostic relevance of anti-filamentous actin antibodies in autoimmune hepatitis. J Clin Pathol 2007; 60: 107–108.
   PubMed Web of Science ®Google Scholar
• Aubert V, Pisler IG, Spertini F. Improved diagnoses of autoimmune hepatitis using an anti-actin ELISA. J Clin Lab Anal 2008; 22: 340–345.
   PubMedGoogle Scholar
• Villalta D, Bizzaro N, Da Re M, Tozzoli R, Komorowski L, Tonutti E. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders. Autoimmunity 2008; 41: 105–110.
   PubMed Web of Science ®Google Scholar
• Jaskowski TD, Konnick EQ, Ashwood ER, Litwin CM, Hill HR. Prevalence of IgG autoantibody against F-actin in patients suspected of having autoimmune or acute viral hepatitis. J Clin Lab Anal 2007; 21: 249–253.
   PubMed Web of Science ®Google Scholar
• Toh BH, Taylor R, Pollock W. F-actin-reactive smooth muscle antibody in subjects with normal liver function. Pathology 2009; 41: 572–575.
   PubMed Web of Science ®Google Scholar
• Clemente MG, Musu MP, Troncone R, et al Enterocyte actin autoantibody detection: a new diagnostic tool in celiac disease diagnosis: results of a multicenter study. Am J Gastroenterol 2004; 99: 1551–1556.
   PubMed Web of Science ®Google Scholar
• Bretherton L, Brown C, Pedersen JS, et al ELISA assay for IgG autoantibody to G-actin: comparison of chronic active hepatitis and acute viral hepatitis. Clin Exp Immunol 1983; 51: 611–616.
   PubMed Web of Science ®Google Scholar
• Cunningham AL, Mackay IR, Frazer IH, et al Antibody to G-actin in different categories of alcoholic liver disease: quantification by an ELISA and significance for alcoholic cirrhosis. Clin Immunol Immunopathol 1985; 34: 158–164.
   PubMedGoogle Scholar